Abstract:Objective To investigate the correlation of stress hyperglycemia with serum levels of C reactive protein(CRP), interleukin-6(IL-6) and macrophage migration inhibiting factor(MIF) that reflect the inflammatory status and with the expression of human leucocyte antigen DR(HLA-DR) on peripheral monocytes in critically illed patients with trauma or infection; and to investigate the effect of intensive insulin therapy and glycemic control on inflammatory response and immune function in critical illness. Methods Thirty-three critically illed patients were randomly divided into the control group(maintenance blood glucose at a level between 9.99 and 11.10 mmol/L), glycemia controlling group 1(maintenance blood glucose at a level between 4.44 and 6.11 mmol/L), and glycemia controlling group 2(maintenance blood glucose at a level between 6.66 and 8.33 mmol/L). Critically illed patients with APACHEⅡscore≥10 after trauma or infection were enrolled. Patients with insulin-dependent diabetes mellitus, immune disease or history of long-term immunoregulating medicine taking were excluded; patients less than 18 years old were also excluded. Target glycemia was obtained by insulin infusion. The glycemia level was determined every one to two hours. The interval of glycemic measurement might prolong when target glycemia was achieved. The expression of human leucocyte antigen DR on peripheral monocytes was measured in all 33 patients with flow cytometry on 1, 4 and 7 of intensive care in parallel with C reactive protein. In the meantime, Enzyme-linked immunoadsorbent assay(ELISA) was used to determine the interleukin-6 and macrophage migration inhibiting factor. The same nutritional support was applied to all patients. Data were expressed as Mean±SD and analyzed by using Analysis of Variance and correlation and linear regression. A p value <0.05 was regarded as statistically significant in all the tests conducted in this study. Results 1) The incidence of stress hyperglycemia was very high, being 97% in this study. There was no hypoglycemia happened in these patients. 2) Compared with the control group and glycemia controlling group 2, glycemia controlling group 1 needed more insulin to achieve target glycemia. 3) There were much increase in serum levels of C reactive protein, interleukin-6 and macrophage migration inhibiting factor and decrease in the expression of human leucocyte antigen DR on peripheral monocytes in all 33 critically illed patients with trauma or infection. C reactive protein was positively correlated with the level of blood glucose, human leucocyte antigen DR was negatively correlated with the level of blood glucose. 4) The levels of C reactive protein, interleukin-6 and macrophage migration inhibiting factor decreased while the expression of human leucocyte antigen DR on peripheral monocytes gradually recovered with the patients improving. 5) Compared with the control group and glycemia controlling group 2, the human leucocyte antigen DR expression of peripheral monocytes in glycemia controlling group 1 increased. There were significant difference on 4 and 7 after admission in Surgical Intensive Care Unit(P<0.05). C reactive protein and interleukin-6 were much decreased on 7 d after intensive insulin therapy(P<0.05); macrophage migration inhibiting factor was also decreased, but the deference was not significant statistically(P>0.05). Conclusion 1) Serum inflammatory factors are much increased in critically ill patients with trauma or infection. Their immune functions are affected. Stress hyperglycemia happens at the same time. Some inflammatory factors are positively correlated with the level of blood glucose. Immune functions are negatively correlatied with the level of blood glucose. Inflammatory factors gradually decrease and immune functions recover with weakening of stress. 2) Tight glucose control with intensive insulin therapy can increase the human leucocyte antigen DR expression of peripheral monocytes. It also can attenuate the systemic inflammatory response in critically illed patients. 3) Control of glycemia to the normal range may have anti-inflammatory and immunoregulatory effect.

Effects of glucose control on the levels of C reactive protein and interleukin-6 in patients with newly onset type 2 diabetics

Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.

[Effects of Non-Surgical Periodontal Treatment on Clinical Response, Serum Inflammatory Parameters, and Metabolic Control of Type 2 Diabetes Patients with Moderate to Severe Periodontitis].

Association Of Periodontal Parameters With Metabolic Level And Systemic Inflammatory Markers In Patients With Type 2 Diabetes

Changes of Blood Pressure,blood Glucose and Blood Lipids Levels after Intensive Treatment in Incipient Diabetes II Patients

Effect of Intensive Multifactorial Treatment on the Intima-Media Thickness of Large Arteries in Patients with New-Onset Type 2 Diabetes Mellitus

Effect of intensive insulin therapy on serum inflammatory factors in newly onset diabetic patients

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Effects of Glargine on the Levels of Malondialdehyde and Hs-Crp in Type 2 Diabetic Patients

Changes in C-reactive Protein in Patients with Type 2 Diabetes after Treatment with Pioglitazone

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity

Effect of Tight Glucose Control on Systemic Inflammatory Response and Immune Function during Critical Illness

Low Serum Total Bilirubin Concentration Was Associated with Increased High Sensitive C Reactive Protein Level in Patients with Impaired Glucose Tolerance and Type 2 Diabetes Mellitus Subjects

The Effect of Short-Term Intensive Insulin Therapy on Circulating T Cell Subpopulations in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Effects of Intensive Glucose Control on Incidence of Cardiovascular Events in Patients with Type 2 Diabetes: A Meta-Analysis

Association Analysis of Acyl Ghrelin,des-Acyl Ghrelin and Its Ratio with Insulin Resistance in Patients with Type 2 Diabetes Mellitus

Analysis of the Variation Levels of APN, Insulin, Sensitive C-Reactive Protein and Leptin in the Serum of Patients with Type 2 Diabetes Mellitus

Effects of Hospital-Community Integrated Management Based on the Joint Diagnosis and Treatment Center for Chronic Diseases in Patients with Type 2 Diabetes Mellitus

Effects of Scaling and Root Planing on Salivary Interleukine-6 Levels in Chronic Periodontitis Patients and Glycemic Controls

Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis.

Comparison of the effect of different short-term intensive anti-diabetic therapies on newly diagnosed type 2 diabetic patients.